A skin condition known as psoriasis can raise the risk of stroke and heart attack, according to reports summarized for readers in North America.
Psoriasis is an autoimmune disease in which the immune system accelerates the turnover of skin cells, leading to red, scaly patches on the surface. The precise cause remains unknown, but research points to a mix of genetics, stress, infections, and certain medications such as nonsteroidal anti inflammatory drugs.
Recent evidence indicates that psoriasis may boost the likelihood of cardiovascular events like heart attack and stroke. Although the exact pathways are still being studied, scientists agree that systemic inflammation associated with psoriasis plays a key role in cardiovascular risk.
In a study conducted by researchers at the University of Padua in Italy, roughly three in ten patients with psoriasis showed reduced blood flow in the smallest vessels of the circulation, even when there was no prior heart disease or blockage in the major arteries. This microvascular dysfunction appears to be driven by inflammatory forces linked to psoriasis and is associated with a heightened risk of developing heart disease.
Leading experts from the American Academy of Dermatology indicate that treating moderate to severe psoriasis can help lower the risk of stroke and heart attack. Colleagues at the United Kingdom National Institute for Health and Care Excellence advise that individuals with this condition receive annual cardiovascular risk assessments to promote prevention and early detection of heart problems.
Reducing the likelihood of cardiovascular events and helping psoriasis improve often involves a combination of medication and lifestyle choices. A focus on minimizing alcohol intake and increasing physical activity is commonly recommended as part of a broader treatment plan.
Earlier warnings from scientists highlighted the potential link between skin symptoms and joint diseases, underscoring the interconnected nature of inflammatory conditions and cardiovascular health. (American Academy of Dermatology) (National Institute for Health and Care Excellence)